For the nine-month period ended December 31, 2025, net sales were 184.666 billion yen (6.5% increase YoY), operating income was 3.657 billion yen (0.8% increase YoY), and net income attributable to owners of parent was 2.236 billion yen (3.8% increase YoY).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7749","jir_company_name":"Medikit Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/7749-20260212-01.pdf","jir_short_summary":"For the nine-month period ended December 31, 2025, net sales were 184.666 billion yen (6.5% increase YoY), operating income was 3.657 billion yen (0.8% increase YoY), and net income attributable to owners of parent was 2.236 billion yen (3.8% increase YoY).","jir_summary":"### Summary of Business Performance\nFor the nine-month period ended December 31, 2025 (April 1, 2025 to December 31, 2025), net sales amounted to 18,466 million yen (6.5% increase YoY), operating income was 3,657 million yen (0.8% increase YoY), ordinary income totaled 3,796 million yen (2.6% increase YoY), and net income attributable to owners of parent was 2,236 million yen (3.8% increase YoY). This growth was mainly driven by increased sales in artificial dialysis products, intravenous catheters, and intervention products.\n\n### Summary of Financial Position\nTotal assets were 51,947 million yen, a 1.0% decrease compared to the same period last year, while net assets increased by 1.0% to 45,605 million yen, and the equity ratio stood at 87.8%, maintaining financial soundness. The decrease in current assets was due to a decline in cash and deposits, with fixed assets remaining virtually unchanged.\n\n### Dividend Status\nThe annual dividend forecast for the fiscal year ending March 2026 is 100 yen (a 10 yen increase YoY), with an interim dividend of 50 yen already paid at the end of the second quarter. There are no revisions to the latest dividend forecast.\n\n### Full-year Consolidated Earnings Guidance\nFor the full fiscal year ending March 2026, the consolidated earnings guidance forecasts net sales of 24,000 million yen (6.4% increase YoY), operating income of 4,500 million yen (0.3% increase YoY), ordinary income of 4,592 million yen (1.4% decrease YoY), net income attributable to owners of parent of 2,924 million yen (3.0% decrease YoY), and earnings per share of 200.75 yen. There are no changes to the latest earnings guidance.","jir_financial_highlights":"Net Sales: 18,466 million yen (6.5% increase YoY)\nOperating Income: 3,657 million yen (0.8% increase YoY)\nOrdinary Income: 3,796 million yen (2.6% increase YoY)\nNet Income Attributable to Owners of Parent: 2,236 million yen (3.8% increase YoY)\nTotal Assets: 51,947 million yen (1.0% decrease YoY)\nNet Assets: 45,605 million yen (1.0% increase YoY)\nEquity Ratio: 87.8% (Increased YoY)\nAnnual Dividend (Forecast): 100 yen (10 yen increase YoY)\nFull-year Earnings Guidance Net Sales: 24,000 million yen (6.4% increase YoY)\nFull-year Earnings Guidance Operating Income: 4,500 million yen (0.3% increase YoY)\nFull-year Earnings Guidance Net Income Attributable to Owners of Parent: 2,924 million yen (3.0% decrease YoY)","jir_category":"","jir_hashtags":"#MedikitCoLtd, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: 18,466 million yen (6.5% increase YoY)\nOperating Income: 3,657 million yen (0.8% increase YoY)\nNet Income Attributable to Owners of Parent: 2,236 million yen (3.8% increase YoY)","jir_meta_title":"Medikit Co., Ltd. Fiscal Year Ending March 2026 Q3 Financial Results: 6.5% Sales Growth, 3.8% Net Profit Increase","jir_meta_description":"Medikit Co., Ltd. announces its Fiscal Year Ending March 2026 Q3 Financial Summary: net sales of 18,466 million yen (6.5% YoY increase), operating income of 3,657 million yen (0.8% YoY increase), and net income attributable to owners of parent of 2,236 million yen (3.8% YoY increase). Annual dividend forecast is 100 yen.","jir_og_title":"Medikit Co., Ltd. Announces Fiscal Year Ending March 2026 Q3 Financial Summary","jir_og_description":"Medikit Co., Ltd. reports increased sales and profits compared to the same period last year, along with an upward revision of dividend forecasts.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Q3\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[17342,18466],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Q3\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[3629,3657],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Q3\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[2155,2236],\\\"borderColor\\\":\\\"#dc3545\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"equity_ratio_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Equity Ratio Trend (%)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Equity Ratio\\\",\\\"data\\\":[86.1,87.8],\\\"borderColor\\\":\\\"#ffc107\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":100}}}}\"}, {\"jir_chart_id\": \"dividend_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Annual Dividend Trend (Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025\\\",\\\"FY2026 (Forecast)\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Annual Dividend\\\",\\\"data\\\":[90,100],\\\"backgroundColor\\\":\\\"#17a2b8\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":17478,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-28561","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n